ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,050.61
-0.39%
Dow Jones
43,449.90
-0.61%
US Dollar vs MXN
20.2002
0.11%
Brent Oil
73.02
-0.12%
Bitcoin
103,701.05
-2.31%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Tissue Regenix Group Plc (TRX) Cotización

Tissue Regenix Group Plc

Tissue Regenix Group Plc (TRX)

TRX Gold Corporation
TRX Gold Corporation
59.50
0.00
(0.00%)
Cerrado 17 Diciembre 10:30AM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
59.50
Postura de Compra
58.00
Postura de Venta
61.00
Volume Operado de la Acción
34,017
59.50 Rango del Día 59.50
50.50 Rango de 52 semanas 74.00
Capitalización de Mercado [m]
41.992M
Precio Anterior
59.50
Precio de Apertura
59.50
Hora
15000
@
59.5
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
139,856
Acciones en circulación
70,574,468
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-138.37
Beneficio por acción (BPA)
-0
turnover
29.49M
Beneficio neto
-302k

Acerca de Tissue Regenix Group Plc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.tissueregenix.com
Sede
Leeds, Gbr
Fundado
-
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 59.50p. Over the last year, Tissue Regenix shares have traded in a share price range of 50.50p to 74.00p.

Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £41.99 million. Tissue Regenix has a price to earnings ratio (PE ratio) of -138.37.

TRX Últimas noticias

Más noticias

Lombard Odier Asset Mgt (Eur) Ltd. Form 8.3 - Tissue Regenix Group PLC

Lombard Odier Asset Mgt (Eur) Ltd. 16 December 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE...

16 Diciembre 2024
RNS Regulatory News

Cavendish Securities PLC Form 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC

Cavendish Securities PLC 16 December 2024   FORM 8.5 (EPT/NON-RI)           PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY...

16 Diciembre 2024
RNS Regulatory News

Cavendish Securities PLC Form 8.5 (EPT/NON-RI)

Cavendish Securities PLC 13 December 2024   FORM 8.5 (EPT/NON-RI)           PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY...

13 Diciembre 2024
RNS Regulatory News

Cavendish Securities PLC Form 8.5 (EPT/NON-RI)

Cavendish Securities PLC 12 December 2024   FORM 8.5 (EPT/NON-RI)           PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY...

12 Diciembre 2024
RNS Regulatory News

Cavendish Securities PLC Form 8.5 (EPT/NON-RI)

Cavendish Securities PLC 11 December 2024   FORM 8.5 (EPT/NON-RI)           PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY...

11 Diciembre 2024
RNS Regulatory News

Lombard Odier Asset Mgt (Eur) Ltd. Form 8.3 - Tissue Regenix Group PLC

Lombard Odier Asset Mgt (Eur) Ltd. 10 December 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE...

10 Diciembre 2024
RNS Regulatory News

Lexham Special Opportunities I LP Form 8.3 - Tissue Regenix Group plc

Lexham Special Opportunities I LP 09 December 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE...

09 Diciembre 2024
RNS Regulatory News

Tissue Regenix Group PLC Holding(s) in Company

Tissue Regenix Group PLC 09 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in...

09 Diciembre 2024
RNS Regulatory News

Lombard Odier Asset Mgt (Eur) Ltd. Form 8.3 - Tissue Regenix Group PLC

Lombard Odier Asset Mgt (Eur) Ltd. 09 December 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE...

09 Diciembre 2024
RNS Regulatory News

IP Group PLC Form 8.3 - Tissue Regenix Group plc

IP Group PLC 06 December 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...

06 Diciembre 2024
RNS Regulatory News
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
11.52.586206896555859.556.62959257.97831523DE
4-1.5-2.45901639344616156.61743357.88795086DE
12-0.5-0.8333333333336064.55213985655.05549555DE
26-5.5-8.461538461546574529052658.07387956DE
523.56.25567450.57261759.49289874DE
1561122.680412371148.57434743474952.36843079DE
260-40.5-40.5100175281817324756.63635587DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TM1Technology Minerals Plc
0.265p
(140.91%)
635.73M
HUMHummingbird Resources Plc
2.30p
(39.39%)
8.51M
QEDQuadrise Plc
6.00p
(29.03%)
28.48M
LPALpa Group Plc
72.00p
(26.32%)
63.26k
DARDar Global Plc
US$ 6.00
(22.45%)
16.75k
APIAbrdn Property Income Trust Limited
9.51p
(-84.36%)
13.57M
KDNCCadence Minerals Plc
1.65p
(-40.00%)
17.87M
BLUBlue Star Capital Plc
0.015p
(-25.00%)
18.2M
SYMESupply@me Capital Plc
0.0034p
(-22.73%)
1.43B
SCGLSealand Capital Galaxy Limited
1.40p
(-22.22%)
6.15M
NTVONativo Resources Plc
0.0021p
(-12.50%)
4.78B
SYMESupply@me Capital Plc
0.0034p
(-22.73%)
1.43B
TRPTower Resources Plc
0.031p
(8.77%)
637.54M
TM1Technology Minerals Plc
0.265p
(140.91%)
635.73M
ORCPOracle Power Plc
0.026p
(-3.70%)
340.06M

Discusión

Ver feed completo
dstock07734 dstock07734 4 minutos hace
You know why I put you on ignore list. Your stupidity is profound. You got lucky this time since I saw your post and replied.

Do you know when Merck started the construction? It was in October 2020. By that time, did Merck have any verifiable data about the efficacy on whatever you ta
NWBO
govprs govprs 7 minutos hace
See page 21 https://www.otcmarkets.com/otcapi/company/financial-report/417444/content
GDVM
agua77 agua77 7 minutos hace
Of course we don’t know that…we only hear promises about “numbers”. That’s how these hopium otc tickers work and on top of it you have a CEO trying to insight emotion as opposed to showing the math.

What’s the worse approach to trading and investing? Emotion
ZHUD
zerosnoop zerosnoop 8 minutos hace
game changer aot
QSEP
Horseb4CarT Horseb4CarT 8 minutos hace
You've probably heard this many times too, but this time is different!
NWBO
zerosnoop zerosnoop 8 minutos hace
proven aot
QSEP
zerosnoop zerosnoop 8 minutos hace
gallagher
QSEP
zerosnoop zerosnoop 8 minutos hace
ceo kyte
QSEP
zerosnoop zerosnoop 9 minutos hace
None of this progress would have been possible without the continued support and patience of our shareholders. Your belief in QS Energy’s mission has been instrumental in our ability to navigate challenges and achieve milestones. As we move forward, we invite you to continue supporting our journey t
QSEP
zerosnoop zerosnoop 9 minutos hace
With these foundational achievements in place, we are now poised for a breakthrough year in 2025. Our focus will be on executing our first customer contracts and launching AOT commercially. We are seeking to finalize debt financing to ensure a smooth operational rollout, and we are confident this wi
QSEP
zerosnoop zerosnoop 9 minutos hace
4. Strengthened Financial Framework: Significant efforts have been made to align our funding strategy with our growth objectives. By focusing on responsible financing, we are working to avoid toxic funding sources, preserving value for our shareholders.
QSEP
zerosnoop zerosnoop 10 minutos hace
3. Path to Commercialization: We took the first steps toward the commercial launch of AOT, with plans to formally enter the market in 2025. This includes securing customer contracts and identifying debt financing to support our operational goals.
QSEP
zerosnoop zerosnoop 10 minutos hace
2. Strategic Partnerships Solidified: Through our collaboration with VIPS Petroleum, we forged strategic agreements with state-owned and private energy companies in Southeast Asia, underscoring the demand for innovative, efficiency-enhancing technology in the region.
QSEP
hondaboost hondaboost 11 minutos hace
Computers trading, it always happens like this: pump to high and dump to low. The machine is irrational!
NUKK
MasterBlastr MasterBlastr 11 minutos hace
Bryson couldn't putt to save his life. Enough to make a difference.
zerosnoop zerosnoop 11 minutos hace
1. Phase 4 Milestone Achieved: We successfully completed Phase 4 testing of AOT with a leading energy producer in Southeast Asia. This achievement validated the effectiveness of our technology in improving oil transport efficiency while reducing carbon emissions.
QSEP
zerosnoop zerosnoop 12 minutos hace
This year marked a pivotal period for QS Energy, highlighted by the continued advancement of our Applied Oil Technology (AOT) and our strategic partnerships across Southeast Asia.
QSEP
Jetmek_03052 Jetmek_03052 12 minutos hace
No. Wrong again. NVDA will report the 4th quarter in February.
NVDA
agua77 agua77 13 minutos hace
Wow…now that’s probably one of the more misinformed things I’ve heard in a bit of time. A R/S here? There are no fundamentals outside of speculations regarding what this merging company “plans” to do, but you think a R/S is going to sustain a share price to get to NASDAQ? lol. I’m glad you’re not ru
ZHUD
mrwrn2010 mrwrn2010 13 minutos hace
We got the approval almost a week earlier than expected so I'm hopeful for a December launch but early January wouldn't be bad either. 

As you mentioned, launching into a shortage is perfect for capturing market share. Bring it home for us, Kirko!
ELTP
zerosnoop zerosnoop 14 minutos hace
January 13, 2025


Dear Shareholders,


Following the close of 2024, I want to take a moment to reflect on how far we’ve come together as a company. This past year has been a transformative one for QS Energy. Thanks to the unwavering support of our shareho
QSEP
NELNEL NELNEL 14 minutos hace
If the recoil prototype is more than $50MM to produce, and the army wont't pay in full until the recoil kits are received, it sounds like the offering is accretive, not dilutive. Buy
VTSI
OTCchaser OTCchaser 15 minutos hace
Cox was flagged as a fraud and can't get approved by the OTC. More evidence that until Cox disappears stock is toast.
CAVR
agua77 agua77 16 minutos hace
Sounds very familiar to the cheerleading at D$GT….wasn’t that suppose to be $’s too?
GT
Griff79 Griff79 20 minutos hace
Still bullish! Easy money from here. 17% increase since I alerted on X. Might see a slight pull back but if it does, there will be someone waiting to buy up the shares.

Good luck. All in my opinion.
LITM

Su Consulta Reciente

LSE
TRX
Tissue Regenix
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados